PLX Conference

Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Published September 02, 2025 at 10:50 AM

(PLX) CARMIEL, Israel, Sept. 2, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein...